Use of Ceftriaxone in the Treatment of Bacterial Infections in Cirrhotic Patients

Overview

Journal Chemotherapy

Specialty Pharmacology

Date 1989 Jan 1

PMID 2612236

Citations 13

Authors

J Mercader

J Gomez

J Ruiz

M C Garre

M Valdes

Affiliations

Soon will be listed here.

Abstract

Sixty-two episodes of bacterial infection were studied in 51 cirrhotic patients. 2 g of ceftriaxone (active ingredient of Rocephin) were given intravenously once daily for 7-10 days. The infections were pneumonia, bacteremia, spontaneous bacterial peritonitis, urinary infection and others. Good responses were seen in 90% of the cases.

Citing Articles

The need for antibiotic stewardship and treatment standardization in the care of cirrhotic patients with spontaneous bacterial peritonitis - a retrospective cohort study examining the effect of ceftriaxone dosing.

Mazer L, Tapper E, Piatkowski G, Lai M F1000Res. 2014; 3:57.

PMID: 25165535 PMC: 4133760. DOI: 10.12688/f1000research.3-57.v2.

Diagnosis and management of bacterial infections in decompensated cirrhosis.

Pleguezuelo M, Manuel Benitez J, Jurado J, Montero J, Mata M World J Hepatol. 2013; 5(1):16-25.

PMID: 23383362 PMC: 3562722. DOI: 10.4254/wjh.v5.i1.16.

A case of cell-free and concentrated ascites reinfusion therapy effective for refractory ascites in spontaneous bacterial peritonitis in a renal transplant patient.

Maeda A, Takeda K, Tsuruya K, Miura S, Toyonaga J, Nakashita S Case Rep Nephrol Urol. 2013; 2(2):138-44.

PMID: 23289021 PMC: 3499181. DOI: 10.1159/000343247.

Prevention and management of bacterial infections in cirrhosis.

Taneja S, Dhiman R Int J Hepatol. 2012; 2011:784540.

PMID: 22229097 PMC: 3168849. DOI: 10.4061/2011/784540.

Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis.

Riggio O, Angeloni S World J Gastroenterol. 2009; 15(31):3845-50.

PMID: 19701963 PMC: 2731245. DOI: 10.3748/wjg.15.3845.